SCHEMBL2155213

SCHEMBL2155213

CC[PH](=O)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
PSIP1 O75475 1/20 0.37
TSHR P16473 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
LMNA P02545 3/20 0.31
MAOB P27338 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ALOX12 P18054 1/20 0.30
ACHE P22303 1/20 0.30
ELANE P08246 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5572993 0.80 TP53 (0.35) TP53PSIP1TSHRALDH1A1GLA
SCHEMBL24370823 0.78 MEN1 (0.46) ALDH1A1CES2CES1MAPTSMN1; SMN2
SCHEMBL6400882 0.77 CES2 (0.37) TSHRCES2CES1SMN1; SMN2
SCHEMBL27380515 0.75 GAA (0.40) TP53TSHRALDH1A1MAPTL3MBTL1
SCHEMBL5138546 0.75 CES2 (0.39) CES2CES1SMN1; SMN2LMNA
SCHEMBL4867131 0.74 MAOB (0.31) ALDH1A1MAPTL3MBTL1LMNAMAOB
SCHEMBL27769844 0.74 LOXL2 (0.38) SMN1; SMN2MAOB
SCHEMBL9347727 0.73 CES2 (0.41) ALDH1A1CES2CES1
SCHEMBL8637868 0.73 CES2 (0.41) ALDH1A1CES2CES1
SCHEMBL27411391 0.73 CES2 (0.41) ALDH1A1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504850-A Chiral phosphonamide compound and application thereof in serving as or preparing agricultural bacteriostat 贵州大学 2025-02-25 CN disclosed
US-20220127533-A1 PHOSPHORUS NITROGEN FLAME RETARDANT, METHOD THEREOF AND MATERIAL COMPRISING THE SAME ZHOU CHONGFU (US) 2022-04-28 US disclosed
EP-3643720-B1 ORGANIC COMPOUNDS, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC ELECTRONIC DEVICE NOVALED GMBH (DE) 2021-09-29 EP disclosed
CN-112409572-A Phosphorus-containing flame-retardant low-thermal-expansion-coefficient epoxy resin, preparation method thereof, related intermediate product and application 苏州巨峰新材料科技有限公司 2021-02-26 CN disclosed
WO-2021031343-A1 PHOSPHORUS-CONTAINING FLAME-RETARDANT LOW-THERMAL-EXPANSION COEFFICIENT EPOXY RESIN, PREPARATION METHOD AND USE THEREOF 苏州巨峰电气绝缘系统股份有限公司 2021-02-25 WO disclosed
EP-3643720-A1 ORGANIC COMPOUNDS, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC ELECTRONIC DEVICE Novaled GmbH (DE) 2020-04-29 EP disclosed
US-10479809-B2 Method for producing alkenyl phosphorus compound MARUZEN PETROCHEMICAL CO., LTD. (JP) 2019-11-19 US disclosed
US-20190263847-A1 METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND MARUZEN PETROCHEMICAL CO., LTD. (JP) 2019-08-29 US disclosed
EP-3184171-B1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2019-03-20 EP disclosed
EP-2858750-B1 PHOSPHINYL GUANIDINE COMPOUNDS, CHROMIUM SALT COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2019-03-13 EP disclosed
US-5292526-A Macroemulsion of non-cationic antibacterial agent COLGATE-PALMOLIVE CO. (US) 1994-03-08 US disclosed
US-5288480-A Antiplaque antibacterial oral composition COLGATE-PALMOLIVE CO. (US) 1994-02-22 US disclosed
US-5192530-A Solubilizer, enhancing agent to aid retention, and delivery enhancement COLGATE-PALMOLIVE COMPANY (US) 1993-03-09 US disclosed
US-5192531-A Triclosan as a water insoluble noncationic additive for dentifrices COLGATE-PALMOLIVE COMPANY (US) 1993-03-09 US disclosed
US-5188821-A ANTIBACTERIAL ANTIPLAQUE ORAL COMPOSITION MOUTHWASH OR LIQUID DENTIFRICE COLGATE-PALMOLIVE COMPANY (US) 1993-02-23 US disclosed
US-5180578-A Adhesion to oral surfaces COLGATE-PALMOLIVE COMPANY (US) 1993-01-19 US disclosed
US-5178851-A Dentifrices treatment with triclosan and carriers COLGATE-PALMOLIVE COMPANY (US) 1993-01-12 US disclosed
US-5032386-A Dentistry COLGATE-PALMOLIVE COMPANY (US) 1991-07-16 US disclosed
US-4119780-A 2(Isopropyldithio)benzimidazole MONSANTO COMPANY (US) 1978-10-10 US disclosed
US-4006155-A Method for preparation of phosphorus polysulfides MONSANTO COMPANY (US) 1977-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10479809-B2 Method for producing alkenyl phosphorus compound ORC3, OR10J3, ORAI3 TP53 3347/4885PSIP1 328/4885TSHR 1438/4885
US-20190263847-A1 METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND ORC3, OR10J3, ALK TP53 3581/4885PSIP1 382/4885TSHR 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.